Evommune EVMN
NYSE EVMN
$7.19 -1.07 (-12.95%)
As of: Oct 1, 2026 · 3:59 PM EDT

Evommune (EVMN) EBT (2024 - 2026)

Updated

Evommune's EBT was -$32.24 million in Q2 2026, compared with -$22.59 million a year earlier.

Analysis

Evommune (EVMN) EBT (2024 - 2026) Analysis & Trends

On a trailing twelve-month basis, Evommune's EBT was -$94.65 million through Jun 30, 2026; for FY2025, it was -$77.75 million.

  • In earlier years, EBT was -$66.77 million in FY2024.
  • The Q2 2026 figure marks the lowest quarterly EBT in data going back to Q3 2024.
  • Per Business Quant data, EVMN's EBT in the three quarters before Q2 2026 was -$21.67 million (Q1 2026), -$28.27 million (Q4 2025) and -$12.47 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 6.75 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.28 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -683.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.27 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.80 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.77 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -10.25 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -653.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.39 Bn
10 Evommune 299.69 Mn -337.83 Mn - -32.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -32.24 Mn
Mar 31, 2026 -21.67 Mn
Dec 31, 2025 -28.27 Mn
Sep 30, 2025 -12.47 Mn
Jun 30, 2025 -22.59 Mn
Mar 31, 2025 -14.42 Mn
Dec 31, 2024 -20.73 Mn
Sep 30, 2024 -15.90 Mn
API Access

Evommune EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=EVMN&period=max&api_key=YOUR_API_KEY